News Archives

News Archives

Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference

Ottawa, ON / TNW-Accesswire / May 1, 2018 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that it will be attending the Bloom …Read More

Avivagen Announces OxC-beta™ Purchase Order with New Customer

Ottawa, ON / TNW-Accesswire / April 25, 2018 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”) is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. Avivagen is pleased to announce that it …Read More

Avivagen Announces the Issuance of Stock Options

Ottawa, ON / TNW-Accesswire / April 13, 2018 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that its Board of Directors has approved …Read More

Avivagen Announces Results From Its Annual General Meeting

Ottawa, ON / TNW-Accesswire / April 10, 2018 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that at the Corporation’s Annual General Meeting …Read More

Avivagen Announces an Amendment to its Stock Option Plan

Ottawa, ON / TNW-Accesswire / April 5, 2018 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that its Board of Directors has approved …Read More

Avivagen Announces Continued Growth and Adoption in the Commercial Use of OxC-beta™ Livestock in the Philippines

Ottawa, ON / TNW-Accesswire / March 26, 2018 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that its partner in …Read More